$T3 Defense(DFNS.US)those of you here, maybe it’s time to pivot to $Shuttle Pharmaceuticals(SHPH.US)👀
T3 Defense Inc. acquires and operates aerospace and defense businesses in the United States and Israel. It engages in supplying generators for iron dome launche...
T3 Defense Inc. staged a low-open rally today, closing 10.15% higher at $10.235, driven by its subsidiary Tiltan's upcoming MSPO 2026 exhibition to expand NATO market penetration and repeated Buy rating from Noble Financial. The stock touched an intraday low of $9.260 in pre-market, then rebounded sharply to a high of $10.250 during regular session, a 10.2% swing. With a market cap of $10.34 million, negative P/B of -0.410 and negative P/E of -0.070, the company remains unprofitable. Price-wise, the stock sits 88.75% below its 52-week high of $91 and 22005.83% above its 52-week low of $0.0463, while still trading well below the 20-day MA of $21.022, indicating weak near-term momentum. However, post-market activity was thin with only 270 shares traded.
T3 Defense fell sharply during regular trading on Tuesday, declining from its pre-market high of $9.79 to $9.47, a drop of approximately 2.8%. The decline was primarily driven by a recent earnings report showing a net loss of $82.488 million for Q2 2026, widening by 2,832.3% year-over-year, alongside a disclosure that the company had failed to satisfy a Nasdaq continued listing standard. Despite a 5.5% pre-market rally to $9.79, the stock quickly reversed after the open, hitting a low of $9.24. The current price of $9.47 remains well below its 20-day MA of $22.37 and 60-day MA of $14.61, and sits 89.6% below its 52-week high of $91, though it is still up 124.4% year-to-date. However, recent contract wins in Israel and expansion into the UAV market, along with a Buy rating from Noble Financial, provide some counterbalance.
T3 Defense fell 8.73% during regular trading to $9.20, driven by a massive Q2 net loss of $82.49 million (down 2,832.3% YoY) and recent common share dilution. The stock declined from a pre-market high of $10.14 to an intraday low of $8.99, forming a steady downward session. Revenue was just $3.996 million with a net profit margin of -2,064.3%. The company disclosed a failure to satisfy a Nasdaq continued listing rule, compounding negative sentiment. The stock is 89.89% below its 52-week high of $91 but still up 118.01% YTD, and trading below both its 20-day ($24.20) and 60-day ($14.45) moving averages. However, after-hours price rebounded to $10.00, suggesting some late buying interest.
T3 Defense opened sharply lower at $10.75 during regular trading and quickly touched $10.70, representing a roughly 9.5% decline from the prior close of $11.82, driven by a significant common share dilution report disclosed in pre-market hours. In pre-market trading, the stock slid from $11.50 to $10.79, with volume of 36,257 shares—nearly four times the regular session's total—reflecting concentrated panic selling. Recent earnings showed a Q2 net loss of $82.5 million, a 28x year-over-year expansion, with EPS of -$173.92 and a net profit margin of -2,064%, underscoring continued fundamental deterioration. However, the company last week announced a strategic partnership with Coincheck Group for digital asset custody in Japan, and its subsidiary Tiltan secured a Majestic.ai software license delivery contract, though these developments failed to offset the decline. The stock now trades far below its 52-week high, with a market cap of just $10.8 million and a turnover rate of 11.85%, indicating highly active positioning.
T3 Defense experienced a persistent intraday decline, driven by lingering market sentiment after the company disclosed a failure to satisfy a continued listing rule. The stock fell from its regular session open of $12.055 to an intraday low of $11.52, closing at $11.83, down roughly 1.9%, and extended losses to $11.70 in post-market trading. While its subsidiary Tiltan recently secured an Israeli defense simulation proof-of-concept order and announced plans to deliver Majestic.ai as licensed software, negative news weighed on the stock. With a current market cap of approximately $11.94 million, a negative price-to-book ratio of -0.47, and the stock trading well below its 52-week high, valuation concerns persist. However, a pre-market high of $12.57 suggests some intraday buying interest existed.
Weekly Recap | T3 Defense -16%, Japan custody deal
T3 Defense Subsidiary Tiltan to Exhibit at MSPO 2026, Advancing NATO Market Expansion | DFNS Stock News
Noble Financial Sticks to Its Buy Rating for T3 Defense (DFNS)
U.S. stock market midday update: T3 Defense down 14.71%, strategic cooperation fails to mask pessimistic sentiment
Coincheck Group and DFNS Announce Strategic Partnership to Bring Institutional-Grade Digital Asset Custody to Japan | CNCK Stock News